San Diego-centered Viking Therapeutics marked alone as a serious competitor within the weight loss drug market place in February following revealing promising facts from the mid-phase trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection As well as in March the c